Literature DB >> 8890232

Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

S Albertí1, D Alvarez, S Merino, M T Casado, F Vivanco, J M Tomás, V J Benedí.   

Abstract

The majority of Klebsiella pneumoniae serum-resistant strains activate complement and bind C3b, the opsonic fragment of C3, without C5b-9 formation and bacterial killing. The mechanisms leading to C3b deposition without cell death were studied, and the results indicate that serum-resistant strains activate principally the alternative pathway and that serum-sensitive strains activate both the alternative and classical pathways. Bacterial molecules implicated in C3b deposition are the outer membrane porin proteins and smooth and rough lipopolysaccharides. Porins activate both complement pathways, and the rough lipopolysaccharide activates the classical pathway, causing deposition of C3b in serum-sensitive strains. The smooth lipopolysaccharide of serum-resistant strains activates only the alternative pathway, impeding the binding of C1q to porins (S. Albertí, G. Marqués, S. Camprubí, S. Merino, J. M. Tomás, F. Vivanco, and V. J. Benedí, Infect. Immun. 61:852-860, 1993; S. Albertí, F. Rodríguez-Quinónes, T. Schirmer, G. Rummel, J. M. Tomás, J. P. Rosenbusch, and V. J. Benedí, Infect. Immun. 63:903-910, 1995) and rough lipopolysaccharide molecules and thereby preventing activation of the classical pathway. After its deposition, C3b is quickly degraded to iC3b on both types of strains, but the higher-level deposition of C3b on serum-sensitive strains, resulting from activation of both the alternative and classical complement pathways, supports further complement activation and killing of serum-sensitive strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890232      PMCID: PMC174438          DOI: 10.1128/iai.64.11.4726-4732.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 2.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

3.  Proteins forming large channels from bacterial and mitochondrial outer membranes: porins and phage lambda receptor protein.

Authors:  H Nikaido
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Chemical modification of carboxyl groups in human Fc gamma fragments: structural role and effect on the complement fixation.

Authors:  F Vivanco-Martínez; R Bragado; J P Albar; C Juarez; F Ortíz-Masllorens
Journal:  Mol Immunol       Date:  1980-03       Impact factor: 4.407

5.  A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.

Authors:  F Praz; M C Roque Antunes Barreira; P Lesavre
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

Review 6.  Complement and bacteria: chemistry and biology in host defense.

Authors:  K A Joiner; E J Brown; M M Frank
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 7.  Klebsiella bacteremia: an analysis of 100 episodes.

Authors:  M García de la Torre; J Romero-Vivas; J Martínez-Beltrán; A Guerrero; M Meseguer; E Bouza
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo.

Authors:  K A Joiner; N Grossman; M Schmetz; L Leive
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

10.  Activation of complement system by porins extracted from Salmonella typhimurium.

Authors:  F Galdiero; M A Tufano; L Sommese; A Folgore; F Tedesco
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more
  35 in total

1.  Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.

Authors:  D Alvarez; S Merino; J M Tomás; V J Benedí; S Albertí
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Porin Loss Impacts the Host Inflammatory Response to Outer Membrane Vesicles of Klebsiella pneumoniae.

Authors:  Kelli L Turner; Bethaney K Cahill; Sarah K Dilello; Dedra Gutel; Debra N Brunson; Sebastián Albertí; Terri N Ellis
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

3.  Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.

Authors:  Sunita Gulati; Andrew Cox; Lisa A Lewis; Frank St Michael; Jianjun Li; Ryan Boden; Sanjay Ram; Peter A Rice
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.

Authors:  C M Fernandez-Prada; M Nikolich; R Vemulapalli; N Sriranganathan; S M Boyle; G G Schurig; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 5.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

6.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

7.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells.

Authors:  Beatriz de Astorza; Guadalupe Cortés; Catalina Crespí; Carles Saus; José María Rojo; Sebastián Albertí
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia.

Authors:  Sunita Shankar-Sinha; Gabriel A Valencia; Brian K Janes; Jessica K Rosenberg; Chris Whitfield; Robert A Bender; Ted J Standiford; John G Younger
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae.

Authors:  B Evrard; D Balestrino; A Dosgilbert; J-L J Bouya-Gachancard; N Charbonnel; C Forestier; A Tridon
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.